Yoshimasa Takahashi
Affiliations: | University of Maryland Baltimore, School of Medicine |
Google:
"Yoshimasa Takahashi"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Takeshita M, Fukuyama H, Kamada K, et al. (2022) Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models. Iscience. 25: 105596 |
| Shimojima M, Sugimoto S, Umekita K, et al. (2022) Neutralizing mAbs against SFTS Virus Gn Protein Show Strong Therapeutic Effects in an SFTS Animal Model. Viruses. 14 |
| Seki Y, Yoshihara Y, Nojima K, et al. (2022) Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants. Med (New York, N.Y.). 3: 406-421.e4 |
| Takano T, Morikawa M, Adachi Y, et al. (2022) Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine. Cell Reports. Medicine. 3: 100631 |
| Shinada K, Sato T, Moriyama S, et al. (2022) Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without Favipiravir. Viruses. 14 |
| Takeshita M, Nishina N, Moriyama S, et al. (2022) Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients. Clinical Immunology (Orlando, Fla.). 238: 108999 |
| Miyamoto S, Arashiro T, Adachi Y, et al. (2022) Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants. Med (New York, N.Y.). 3: 249-261.e4 |
| Ishii H, Nomura T, Yamamoto H, et al. (2022) Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8 T cell responses. Cell Reports. Medicine. 3: 100520 |
| Kotaki R, Adachi Y, Moriyama S, et al. (2022) SARS-CoV-2 Omicron-neutralizing memory B-cells are elicited by two doses of BNT162b2 mRNA vaccine. Science Immunology. eabn8590 |
| Fujigaki H, Yamamoto Y, Koseki T, et al. (2022) Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2. Microbiology Spectrum. e0118121 |